Thoracic Oncology Program
The Thoracic Oncology Program includes investigators interested in tumors of the respiratory tract, including lung, head and neck malignancy. Focus areas include:
- prevention
- biomarkers and early detection
- genetics and tumor biology
- experimental therapeutics.
Scientific Goal
To decrease the incidence and motality of thoracic and head and neck cancers.
Program Goal
- To increase productive interactions between individual basic science members, translational scientists and clinical scientists
- To recruit new investigators who will interact creatively with the Thoracic Oncology Program
Program Activities
- Career Development Grant
- Pilot Project Grants
- Monthly Seminar Series
Program Members
The Thoracic Oncology Program is comprised of 44 members (30 Full and 14 Associate). Six of the Full Members also hold joint membership in the Developmental Therapeutics, Carcinogenesis/Chemoprevention or Cancer Cell Biology Programs. Member interests include smoking cessation, biomarkers and early detection, epithelial carcinogenesis, tumor genetics and biology, chemoprevention and therapy. View member list.
Publications
The Thoracic Oncology Program produced 87 cancer-related publications in 2006-2007. Of these, 35 (40%) were inter-programmatic or inter- and intra-programmatic publications; 31 (36%) were intra-programmatic or inter- and intra-programmatic publications. View publications (pdf)